Summary: "Recombinant Anti-B cell lymphoma BCL1 Idiotype x Anti-CD3 Bispecific Antibody (TandAb) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy. https://www.creative-biolabs.com/bsab/symbolsearch-b%2520cell%2520lymphoma%2520bcl1%2520idiotype%2520%2526%2520cd3.htm"
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
